ProceduresGovernment

Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof)

Código 293969 (Harmonized System 2012 by 6 digits)

  2023: US$280k, International Purchases

The states with the most international purchases in 2023 were Ciudad de México (US$276k).

The main commercial origins of Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) in 2023 were Italy (US$120k), Czech Republic (US$94.8k), India (US$51.9k), Germany (US$8.92k), and France (US$999).

In the global context, the main exporting countries of Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) in 2022 were Czech Republic (US$37.9M), Italy (US$14.4M), and China (US$5.84M). In the same year, the main importing countries of Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) were Japan (US$11.5M), Italy (US$7.61M), and China (US$5.91M).

Trade Balance of Mexico

#permalink to section

Net Trade Balance

#permalink to section

The visualizations show the net balance of Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.

Net International Trade

#permalink to section

July, 2023: US$120k, International Purchases

In July 2023, international sales of Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) were US$0, while international purchases reached US$120k. The above results in a trade balance of -US$120k.

Exchange by Territory

#permalink to section

International Purchases

#permalink to section

Ciudad de México: US$276k, State with the Most International Purchases (2023)

Italy: US$120k, Main Commercial Origin (2023)

In 2023, the states with the highest international in Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) were Ciudad de México (US$276k).

The countries with the most international sales to Mexico in 2023 were Italy (US$120k), Czech Republic (US$94.8k), India (US$51.9k), Germany (US$8.92k), and France (US$999).

Specialization

#permalink to section

Specialization by State

#permalink to section

The RCA-Complexity  diagram compares the Revelead Comparative Advantages of states in Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof)  and the Economic Complexity Index of each state.

RCA values ​​greater than 1 indicate that the state has comparative advantages in Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.

Origins and Trade Destinations

#permalink to section

  • 0.0017%, Mexican share in global exports - 2022
  • 1.19%, Mexican share in global imports - 2022

The visualizations show the global market for Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof). In both charts, Mexico stands out in order to identify its participation in the export and import market.

In 2022, the main exporting countries of Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) were Czech Republic (US$37.9M), Italy (US$14.4M), and China (US$5.84M). In the same year, the main importing countries for Ergot Alkaloids of Rye and its Derivatives; Salts Thereof (Excl. Ergometrine, Ergotamine, Lysergic Acid and Salts Thereof) were Japan (US$11.5M), Italy (US$7.61M), and China (US$5.91M).